Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial

Background and Aims Relapse to addiction following incarceration is common. We estimated the feasibility and effectiveness of extended‐release naltrexone (XR‐NTX) as relapse prevention among opioid‐dependent male adults leaving a large urban jail. Design Eight‐week, proof‐of‐concept, open‐label, non...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Addiction (Abingdon, England) England), 2015-06, Vol.110 (6), p.1008-1014
Hauptverfasser:	Lee, Joshua D., McDonald, Ryan, Grossman, Ellie, McNeely, Jennifer, Laska, Eugene, Rotrosen, John, Gourevitch, Marc N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Adults Cocaine Confidence intervals Delayed-Action Preparations Extended-release naltrexone Health care Hospitals Humans Imprisonment Injections, Intramuscular jail Male Medical treatment Naltrexone - administration & dosage Narcotic Antagonists - administration & dosage Narcotics New York City opioid dependence Opioid-Related Disorders - rehabilitation Pilot Projects Prisoners Prisons randomized controlled trial Recurrence relapse prevention Treatment Outcome Urine Vivitrol
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!